Tevimbra Approved for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemo

The FDA approved tislelizumab-jsgr as monotherapy for certain adult patients with esophageal squamous cell ...

MARCH 19, 2024